Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | MYGNMyriad Genetics IncFY2025 · Dec |
|---|---|
| Revenue | $824.50M |
| Revenue, yoy | −1.6% |
| Net income | $365.90M |
| Net income, yoy | −187.4% |
| Net margin | -44.4% |
| Free cash flow | $151.60M |
| FCF margin | — |
| EPS, diluted | $3.95 |
Add another company.